CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
Author
A Bacic
A Chan
+22Â more
A Chan
A Jonas
B Li
B Li
C Qi
C Salvador
C. E. Halstenson
CS Zent
F Schneller
K Fraser
M Tamayo
M. A. Gargano
M. L. Patchen
N Bose
N Bose
N Segal
R Luigina
R. M. Walsh
S Leonardo
T. Shamp
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
W Engel-Reidel
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Full text link
